| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 80.93 | 95112 |
| Intrinsic value (DCF) | 0.36 | 324 |
| Graham-Dodd Method | n/a | |
| Graham Formula | 63.40 | 74488 |
Datametrex AI Limited is a Canadian technology company leveraging artificial intelligence and machine learning to transform data analytics across multiple sectors. Headquartered in Toronto and operating in Canada and South Korea, the company operates through two primary segments: AI and Technology, and Health Security. Datametrex specializes in collecting, analyzing, and presenting both structured and unstructured data using patented AI technologies. The company's diverse service portfolio includes health security solutions such as COVID-19 testing kits and telemedicine services through its Medi-Call health app, alongside advanced AI-driven platforms like NexaSecurity for social media monitoring and Datametrex EV solutions. Operating in the competitive Information Technology Services sector, Datametrex positions itself at the intersection of healthcare technology and artificial intelligence, targeting the growing demand for data-driven solutions in both corporate and consumer markets. The company's international presence, particularly in South Korea's advanced technology market, provides strategic access to Asian markets while maintaining its North American foundation.
Datametrex AI presents a high-risk investment proposition characterized by significant financial challenges and operational uncertainty. The company reported a net loss of CAD 3.06 million on revenue of CAD 6.49 million for the period, with negative operating cash flow of CAD 1.22 million and a concerning debt-to-equity position with total debt of CAD 1.84 million against cash reserves of only CAD 0.37 million. The diluted EPS of -CAD 0.16 reflects ongoing profitability challenges. While the company operates in growth sectors including AI and health technology, its financial performance indicates substantial execution risk. The beta of 1.404 suggests higher volatility than the market average, which may appeal to speculative investors but warrants caution for risk-averse portfolios. The absence of dividends and the company's micro-cap status (CAD 2.7 million market capitalization) further underscore the speculative nature of this investment, suitable only for investors with high risk tolerance and a long-term perspective on AI and healthcare technology convergence.
Datametrex AI operates in a highly competitive landscape where it faces challenges in establishing sustainable competitive advantages. The company's diversification across AI technology and health security creates both opportunities and strategic complexities. In the AI and data analytics segment, Datametrex competes against well-established players with significantly greater resources and technical capabilities. The company's NexaSecurity platform and social media monitoring technologies represent niche offerings in a market dominated by comprehensive enterprise solutions. The health security segment, particularly COVID-19 related services, faces declining demand as pandemic-related testing requirements diminish globally. While the Medi-Call telemedicine platform addresses growing digital health trends, it competes in an increasingly crowded telemedicine market where scale and integration with healthcare systems are critical success factors. Datametrex's international operations in South Korea provide geographic diversification but also expose the company to competitive pressures in one of the world's most technologically advanced markets. The company's small market capitalization and limited financial resources constrain its ability to invest in research and development at the scale required to compete effectively against larger technology and healthcare companies. Without clear technological differentiation or sustainable market leadership in any specific segment, Datametrex faces significant challenges in achieving scalable growth and profitability in either of its operating divisions.